Blood Salvage and Allogenic Transfusion Needs in Revision Hip Arthroplasty

Garvin, Kevin L.; Feschuk, Connie A; Sekundiak, Todd D.; Lyden, Elizabeth

doi:10.1097/01.blo.0000192033.50316.bf

Cited by 34 publications

(30 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Goulet et al [2] found that transfusion requirements were decreased when Cell Saver was used in orthopedic procedures. McMurray et al [1] and Garvin et al [11] found that Cell Saver decreased the need for donor blood transfusion in primary and revision hip arthroplasty. Cell Saver has also been shown to decrease the amount of other blood transfusions in children undergoing acetabuloplasty [12].…”

Section: Discussionmentioning

confidence: 99%

Cell Saver: Is it beneficial in scoliosis surgery?

Weiss

Skaggs

Tanner

et al. 2007

Journal of Children's Orthopaedics

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Cell Saver: Is it beneficial in scoliosis surgery?

Weiss

Skaggs

Tanner

et al. 2007

Journal of Children's Orthopaedics

View full text Add to dashboard Cite

show abstract

“…Garvin et al could show that the need for ABT using two different systems for CATS was reduced in cases of hip revision by 31 % [44]. Zarin et al found decreased perioperative blood loss using CATS for patients with revision of femoral and acetabular components or only the acetabular component [23].…”

Section: Discussionmentioning

confidence: 99%

Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty

Hawi

Kendoff

Hessling

et al. 2014

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

Purpose The goal of this study was to analyse the efficacy of blood autotransfusion using a continuous autologous transfusion system in revisions of total hip arthroplasty (THA). We looked at whether administration of allogeneic blood units was reduced in these cases and if there is a difference between cemented and non-cemented revisions. Methods Between January 2011 and December 2011, patients being treated with revision THA were included (n=411). The following parameters were analysed: patient age, gender, weight (kg), height (cm), body mass index (BMI, kg/m 2 ), surgical diagnosis, treatment and American Society of Anesthesiologists (ASA) classification score. The difference between pre-and post-operative haemoglobin (Hb, g/dl), amount of peri-operative blood loss (ml), amount of retransfused washed shed blood and amount of allogeneic and/or autologous transfusion (ml) were recorded. Results In both the cemented and non-cemented revision THA groups, there was no significant difference between pre-and post-operative Hb with or without using an autotransfusion system. In 92 of 186 cemented cases using an autologous transfusion system (49.5 %) and 38 of 117 non-cemented cases using an autologous transfusion system (32.5 %), allogeneic blood transfusion (ABT) was required. Cemented procedures using an autologous transfusion system got significantly more ABTs than non-cemented procedures using an autologous transfusion system (p=0.0042, odds ratio=2.035).Conclusions Use of an autologous transfusion system did not reduce the amount of ABT in revision THA in the patient cohort reported here. In our opinion, general blood management is required before and during surgery to reduce administration of ABT.

show abstract

“…Garvin et al [12] reported total blood loss was greatest for femoral revision than for acetabular revision in 147 patients undergoing revision THA. Zarin et al [29] reviewed the records of 126 patients undergoing revision THA and found the greatest blood loss occurred when both components were revised, while the blood loss when only one component was revised was not different between femoral component revision and acetabular revision.…”

Section: Discussionmentioning

confidence: 99%

Tranexamic Acid Reduces Allogenic Transfusion in Revision Hip Arthroplasty

Noordin

Waters

Garbuz

et al. 2011

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

Background Revision THA is associated with high blood loss and a high probability of blood transfusion in the perioperative period. In November 2003, government legislation established the Blood Utilization Program at our center to reduce the rate and risks associated with allogenic transfusion. Questions/purposes The purposes of this study were to (1) determine whether the allogenic transfusion rate in patients undergoing revision THA decreased in those who were reviewed preoperatively by the Blood Utilization Program versus those who were not; (2) determine whether tranexamic acid reduced the rate of transfusion; and (3) identify potential perioperative clinical parameters that are associated with an increased risk of blood transfusion. Methods We included all 159 patients who underwent revision THA from

show abstract

Blood Salvage and Allogenic Transfusion Needs in Revision Hip Arthroplasty

Abstract: Therapeutic study, Level IV (case series). See the Guidelines for Authors for a complete description of levels of evidence.

Cited by 34 publications

References 14 publications

Cell Saver: Is it beneficial in scoliosis surgery?

Cell Saver: Is it beneficial in scoliosis surgery?

Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty

Tranexamic Acid Reduces Allogenic Transfusion in Revision Hip Arthroplasty

Contact Info

Product

Resources

About